Baltimore, Maryland, USA, September 22, 2020: The Global Virus Network (GVN), comprising foremost experts around the world in every class of virus-causing disease in humans and some animals, today presented Doherty Institute Director, University of Melbourne Professor Sharon Lewin with the Robert C. Gallo Award for Scientific Excellence and Leadership in Medical Virology Presented today at the GVN Special Annual Meeting, Professor Lewin was selected for her outstanding clinical virology research and clinical trials, her leadership in Australian medical science as Director of the Doherty Institute, and her leadership in the GVN.
Professor Lewin has an international reputation in the field of HIV latency and eradication and immune reconstitution and HIV-hepatitis B virus co-infection.
In 2020 she has worked tirelessly at the helm of the Doherty Institute which has been at the forefront of Australia’s response to the COVID-19 pandemic.
Professor Lewin said it was an incredible honour to be presented with the Robert Gallo Award.
“The GVN is among other things, dedicated to identifying, research, combatting and preventing current and emerging pandemic viruses, it’s reason for being has never been so relevant. It’s a privilege to receive the Robert Gallo Award, and to be so closely linked as a GVN Center of Excellence Director,” Professor Lewin said.
The Doherty Institute is one of 57 GVN global Centers of Excellence, which Professor Lewin co-leads with Professor Damian Purcell and Professor Peter Revill.
The award is named after GVN Co-Founder and International Scientific Advisor, Professor Robert Gallo, who is most widely known for his co-discovery of HIV as the cause of AIDS and the development of the HIV blood test.
“Sharon Lewin is an international leader in clinical research,” said Professor Robert C. Gallo, co-founder of GVN and the current Director of the Institute of Human Virology at the University of Maryland School of Medicine. “Additionally, she has been, and will continue to be, a medical science thought leader for the field of clinical virology and a powerful presence in Australia and globally as a scientific leader of the Doherty Institute, quickly establishing this GVN Center as one of excellence. I know all in the GVN are very happy and proud to honor her.”
“I congratulate Sharon Lewin for such a well-deserved award,” said GVN President Professor Christian Bréchot. “Indeed, this recognizes her major scientific achievements and her full commitment to both the fight against HIV and support for the Global Virus Network.”
About the Global Virus Network (GVN)
The GVN is essential and critical in the preparedness, defense and first research response to emerging, exiting and unidentified viruses that pose a clear and present threat to public health, working in close coordination with established national and international institutions. It is a coalition comprised of eminent human and animal virologists from 57 Centers of Excellence and 10 Affiliates in 33 countries worldwide, working collaboratively to train the next generation, advance knowledge about how to identify and diagnose pandemic viruses, mitigate and control how such viruses spread and make us sick, as well as develop drugs, vaccines and treatments to combat them. No single institution in the world has expertise in all viral areas other than the GVN, which brings together the finest medical virologists to leverage their individual expertise and coalesce global teams of specialists on the scientific challenges, issues and problems posed by pandemic viruses. The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org and follow on Twitter @GlobalVirusNews.